Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-001942
Filing Date
2025-03-17
Accepted
2025-03-17 16:29:31
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 5432
  Complete submission text file 0001950047-25-001942.txt   7017
Mailing Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494 617-916-5445
Candel Therapeutics, Inc. (Subject) CIK: 0001841387 (see all company filings)

EIN.: 522214851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40629 | Film No.: 25744909
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address CANDEL THERAPEUTICS, INC. 117 KENDRICK ST., SUITE 450 NEEDHAM MA 02494
Business Address
Schoch Charles (Reporting) CIK: 0002007349 (see all company filings)

Type: 144